CA
NZ
UK
AU
IND
US
Johnson & Johnson announced positive Phase 3 results for ICOTYDE (icotrokinra) in biologic-naive adults with active psoriatic arthritis, presented as a late-breaking poster at the American College of Rheumatology Convergence 2026 on November 7, 2026.
Mark Barrocas, Chief Executive Officer and Director of SharkNinja, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 113,156 ordinary shares across seven transactions on that same date.
Joshua H. Maxfield, VP and General Counsel of Garmin Ltd, filed a Form 4 on November 6, 2026, disclosing a disposition of 5 registered shares gifted to a charitable organization on November 5, 2026.
Alvin M. Bodford and AMB Investments LLC filed Amendment No. 3 to their Schedule 13D regarding Guerrilla RF, Inc. common stock on November 6, 2026, disclosing a triggering event dated November 4, 2026.
Salem Investment Partners V, Limited Partnership, SIP V Management LLC, and Badger Capital II, L.L.C. filed Amendment No. 2 to their Schedule 13D with the SEC on November 6, 2026, disclosing their combined beneficial ownership in Guerrilla RF, Inc. as of November 4, 2026.
Director Daniel V. Leff filed a Form 4 with the SEC on November 6, 2026, disclosing the vesting of 2,410 restricted stock units in FuboTV Inc. (NYSE:FUBO) and reporting his resulting beneficial ownership positions.
FuboTV Inc. director Jonathan Scott Headley filed a Form 4 on November 6, 2026, reporting the vesting of 2,410 restricted stock units and the acquisition of an equal number of Class A common shares on that same date.
Director Andrew Peter Bird filed a Form 4 with the SEC on November 6, 2026, reporting the vesting and conversion of 2,410 restricted stock units into an equal number of shares of FuboTV Inc. Class A common stock on the same date.
Director Ignacio Figueras filed a Form 4 with the SEC on November 6, 2026, reporting the vesting and conversion of 2,410 restricted stock units into shares of FuboTV Inc. Class A common stock on the same date.
ACM Research, Inc. Chief Operations Officer Yue Ma received stock option and restricted stock unit grants on October 1, 2026, according to a Form 4 filed with the SEC on November 6, 2026.
Please wait processing your request...